Enfusion, Inc.
ENFN · NYSE
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $53 | $51 | $49 | $48 |
| % Growth | 3.5% | 3.5% | 2.9% | – |
| Cost of Goods Sold | $16 | $16 | $16 | $16 |
| Gross Profit | $37 | $35 | $33 | $32 |
| % Margin | 69% | 68.1% | 67.7% | 66.3% |
| R&D Expenses | $7 | $7 | $6 | $7 |
| G&A Expenses | $21 | $19 | $19 | $20 |
| SG&A Expenses | $28 | $25 | $25 | $26 |
| Sales & Mktg Exp. | $7 | $6 | $6 | $6 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $35 | $32 | $31 | $33 |
| Operating Income | $2 | $3 | $3 | -$1 |
| % Margin | 3% | 5.8% | 5.5% | -2.3% |
| Other Income/Exp. Net | $1 | -$0 | $0 | $0 |
| Pre-Tax Income | $2 | $3 | $3 | -$1 |
| Tax Expense | $2 | $1 | $0 | -$0 |
| Net Income | $0 | $1 | $2 | -$1 |
| % Margin | 0.2% | 2.8% | 3.7% | -1.1% |
| EPS | 0.001 | 0.021 | 0.02 | -0.006 |
| % Growth | -93.8% | 6.6% | 430% | – |
| EPS Diluted | 0.001 | 0.015 | 0.014 | -0.006 |
| Weighted Avg Shares Out | 94 | 93 | 92 | 90 |
| Weighted Avg Shares Out Dil | 130 | 129 | 129 | 128 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $3 | $3 | $3 |
| EBITDA | $2 | $6 | $6 | $2 |
| % Margin | 3% | 11.6% | 11.3% | 3.2% |